Aurobindo Pharma USA, Inc. is a generic pharmaceutical manufacturer and distributor and is a wholly owned subsidiary of Aurobindo Pharma Limited, a leading generic pharmaceutical company based in India. Headquartered in HITEC City, Hyderabad, India, founded in 1986 and becoming a public company in India in 1992.
Aurobindo Pharma USA, Inc. is committed to delivering a broad portfolio of quality, affordable generic pharmaceuticals to pharmacists and patients. Aurobindo Pharma USA, Inc. adds value through superior customer service in the distribution of a broad line of generic pharmaceuticals, leveraging vertical integration and efficient controlled processes. Aurobindo has business operations in more than 125 countries around the world. Aurobindo is a global pharmaceutical company with a broad portfolio of generic drugs that includes more than 180 product families and 450 individual product packages.
Growth:
3rd largest pharmaceutical company in the US by volume
Fastest growth rate among Top 10 pharmaceutical companies
Over 180 actively marketed product families
Once Acquisition Closes:
2nd Largest Company in terms of volume
Over 400 product families actively marketed
Over 100 non-marketed ANDA’s ready for relaunch
Over 220 ANDA’s pending approval, market value in excess of $80B
Over 40 Product Launches planned for current fiscal year
Nearly 1 in 10 scripts dispensed will be an Aurobindo generic product
